FDA grants breakthrough therapy designation to Lilly's lung cancer drug
PositiveFinancial Markets

The FDA has granted breakthrough therapy designation to Lilly's new lung cancer drug, which could expedite its development and approval process.
— via World Pulse Now AI Editorial System